🟠 Moderate Evidence
A large prospective cohort study of more than 112,000 participants has identified eight common food preservatives associated with significantly elevated risks of hypertension, myocardial infarction, stroke, and other cardiovascular events. The research, which tracked participants for up to eight years, found that individuals consuming the highest amounts of certain additives had substantially greater cardiovascular risk profiles compared with those with minimal exposure.
Key takeaways
- More than 112,000 participants tracked for up to 8 years; highest additive consumers showed significantly elevated cardiovascular risks
- Eight specific preservatives identified as linked to hypertension, heart attack, and stroke risk
- Findings suggest public health policies on food additive labelling and consumption limits warrant reassessment
- Observational design means causation cannot be definitively established; further intervention studies needed
Study at a Glance
| Source | Prospective cohort study (ScienceDaily) |
| Study type | Observational cohort |
| Sample size | N = 112,000+ |
| Follow-up duration | Up to 8 years |
| Primary outcome | Hypertension, myocardial infarction, stroke, cardiovascular disease |
Cardiovascular Risk Profile: High vs. Low Additive Consumption
Relative risk elevation across disease categories (prospective cohort data)
Source: Prospective Cohort Study, 112,000+ participants | Georgian Medical Journal News
Dose-Response Pattern Observed Across Multiple Cardiovascular Endpoints
The research demonstrates a dose-dependent relationship between preservative consumption and cardiovascular risk. Participants in the highest consumption quartile exhibited substantially greater incidence of hypertension, acute myocardial infarction, cerebrovascular accident, and composite cardiovascular disease outcomes compared with the lowest consumption group.
This pattern aligns with established mechanisms by which certain additives may adversely affect endothelial function, blood pressure regulation, and inflammatory pathways. The consistency of association across multiple disease categories strengthens the biological plausibility of the observations, though observational data cannot establish definitive causation.
Regulatory Status and Current Dietary Exposure Levels
The eight preservatives identified in this analysis are currently approved for food use in most major regulatory jurisdictions, including the United States Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA). Despite regulatory clearance based on historical safety assessments, contemporary epidemiological evidence increasingly suggests that long-term dietary exposure patterns warrant reassessment.
Intake levels among high consumers in this cohort may reflect cumulative exposure across multiple processed food categories—a dietary pattern increasingly common in industrialised nations. The populations most affected by high preservative intake tend to be those with limited access to fresh foods, raising equity concerns about additive exposure and cardiovascular disease burden.
Implications for Public Health and Clinical Practice
If the association documented in this large prospective study reflects a causal relationship, the public health implications are substantial. Current dietary guidance emphasises reduction of sodium and ultra-processed food intake, both of which correlate with high preservative consumption. This research provides additional mechanistic rationale for such recommendations within the context of global cardiovascular disease prevention initiatives.
Clinicians counselling patients at elevated cardiovascular risk—particularly those with existing hypertension, diabetes, or prior cardiovascular events—may benefit from directing patients toward unprocessed and minimally processed foods. Food manufacturers and regulatory bodies should consider whether current additive approval frameworks adequately capture long-term population-level health outcomes at contemporary consumption levels.
Study Limitations and Path Forward for Research
The observational cohort design, while providing robust evidence of association, cannot definitively establish causation. Residual confounding by unmeasured diet quality factors, physical activity, or genetic predisposition remains possible. Reverse causation—whereby individuals with early cardiovascular disease alter their diet—cannot be entirely excluded despite prospective follow-up.
Randomised controlled trials examining the effects of additive reduction on blood pressure and cardiovascular outcomes would strengthen causal inference. Additionally, mechanistic studies elucidating the pathways by which specific additives affect endothelial function, blood pressure, and inflammatory markers are warranted. International collaborative efforts through organisations such as the World Health Organization’s Nutrition and Food Safety unit may be valuable in harmonising regulatory approaches to food additive safety assessment based on emerging epidemiological evidence.
In a prospective cohort of 112,000+ participants followed for up to 8 years, consumption of eight common food preservatives was associated with significantly elevated risks of hypertension, myocardial infarction, stroke, and other cardiovascular endpoints, with highest-consumption groups demonstrating substantially greater disease incidence than lowest-consumption groups.
— Prospective Cohort Study (ScienceDaily, 2026)
What this means
Frequently asked questions
Does this study prove that food additives cause heart disease?
No. This observational cohort study demonstrates a strong association between high preservative consumption and cardiovascular risk, but cannot establish definitive causation. Confounding variables—such as overall diet quality, physical activity, or genetic factors—may partly explain the observed associations. Randomised controlled trials would be needed to prove causation, though such trials in this context are methodologically challenging.
Are these additives currently legal and considered safe?
Yes, all eight preservatives identified in this study are currently approved for food use by regulatory agencies including the FDA and EFSA. However, regulatory approval is typically based on acute toxicity and short-term safety data rather than long-term population-level cardiovascular outcomes. This research suggests that long-term safety reassessment may be warranted in light of contemporary epidemiological evidence.
What practical steps can individuals take based on this research?
The most straightforward approach is to increase consumption of unprocessed and minimally processed foods—fresh fruits, vegetables, whole grains, legumes, nuts, and fresh proteins—while reducing reliance on packaged, processed foods where preservatives are concentrated. Reading nutrition labels and choosing products with shorter ingredient lists and fewer additives aligns with both this research and established cardiovascular prevention guidelines.
The findings from this large prospective cohort study underscore the importance of integrating contemporary nutritional epidemiology into food safety and dietary guidance frameworks. As the global burden of cardiovascular disease remains the leading cause of mortality worldwide—accounting for approximately 17.9 million deaths annually according to WHO estimates—even modest reductions in modifiable dietary risk factors merit serious policy attention. Future research combining observational evidence with mechanistic investigation will be essential to translate these findings into evidence-based regulatory and public health action. For further exploration of cardiovascular prevention through dietary intervention, see our Clinical Updates section.
Source: Researchers found 8 common food additives linked to high blood pressure and heart disease
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
